Velan Capital Investment Management as of Sept. 30, 2025
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 49 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 10.4 | $11M | 8.8M | 1.26 | |
| Cidara Therapeutics Com New (CDTX) | 9.8 | $10M | 108k | 95.76 | |
| Protara Therapeutics Com Stk (TARA) | 8.7 | $9.3M | 2.1M | 4.35 | |
| Rezolute Com New (RZLT) | 6.6 | $7.1M | 750k | 9.40 | |
| Praxis Precision Medicines I Com New (PRAX) | 6.6 | $7.0M | 133k | 53.00 | |
| Mineralys Therapeutics (MLYS) | 6.3 | $6.7M | 176k | 37.92 | |
| Jasper Therapeutics Com New (JSPR) | 5.8 | $6.2M | 2.7M | 2.32 | |
| Abivax Sa Sponsored Ads (ABVX) | 5.1 | $5.5M | 64k | 84.90 | |
| Inspiremd (NSPR) | 4.9 | $5.2M | 2.1M | 2.41 | |
| Zooz Pwr Share (ZOOZ) | 4.0 | $4.3M | 2.0M | 2.14 | |
| Alumis (ALMS) | 3.5 | $3.8M | 947k | 3.99 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 3.5 | $3.8M | 74k | 51.29 | |
| Avalo Therapeutics Com New (AVTX) | 3.1 | $3.4M | 264k | 12.71 | |
| Sutro Biopharma (STRO) | 2.5 | $2.7M | 3.1M | 0.87 | |
| Eupraxia Pharmaceuticals (EPRX) | 2.0 | $2.1M | 352k | 5.90 | |
| Rapt Therapeutics Com New (RAPT) | 1.9 | $2.1M | 80k | 25.79 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $2.0M | 130k | 15.38 | |
| Trevi Therapeutics (TRVI) | 1.8 | $1.9M | 205k | 9.15 | |
| Uniqure Nv SHS (QURE) | 1.8 | $1.9M | 32k | 58.37 | |
| Miragen Therapeutics (VRDN) | 1.8 | $1.9M | 87k | 21.58 | |
| Edesa Biotech Com New (EDSA) | 1.6 | $1.7M | 688k | 2.47 | |
| Tela Bio (TELA) | 1.0 | $1.1M | 747k | 1.49 | |
| Eledon Pharmaceuticals (ELDN) | 0.8 | $899k | 347k | 2.59 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.7 | $772k | 61k | 12.65 | |
| Tenax Therapeutics Com New (TENX) | 0.6 | $634k | 83k | 7.61 | |
| Tourmaline Bio (TRML) | 0.3 | $277k | 5.8k | 47.83 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $255k | 80k | 3.19 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $246k | 3.7k | 66.43 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $224k | 6.5k | 34.49 | |
| Ovid Therapeutics (OVID) | 0.2 | $208k | 160k | 1.30 | |
| Gossamer Bio (GOSS) | 0.2 | $184k | 70k | 2.63 | |
| Alector (ALEC) | 0.2 | $163k | 55k | 2.96 | |
| Design Therapeutics (DSGN) | 0.1 | $151k | 20k | 7.53 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $150k | 20k | 7.51 | |
| Nurix Therapeutics (NRIX) | 0.1 | $148k | 16k | 9.24 | |
| Erasca (ERAS) | 0.1 | $142k | 65k | 2.18 | |
| Ventyx Biosciences (VTYX) | 0.1 | $124k | 40k | 3.11 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $122k | 55k | 2.22 | |
| Immunome (IMNM) | 0.1 | $117k | 10k | 11.71 | |
| Precision Biosciences Com New (DTIL) | 0.1 | $110k | 20k | 5.52 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $110k | 15k | 7.32 | |
| Geron Corporation (GERN) | 0.1 | $110k | 80k | 1.37 | |
| Larimar Therapeutics (LRMR) | 0.1 | $107k | 33k | 3.23 | |
| Context Therapeutics (CNTX) | 0.1 | $97k | 100k | 0.97 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $96k | 45k | 2.13 | |
| Replimune Group (REPL) | 0.1 | $84k | 20k | 4.19 | |
| Immix Biopharma (IMMX) | 0.1 | $73k | 35k | 2.09 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $62k | 33k | 1.90 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $49k | 35k | 1.40 |
